HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Drug Pipeline
RCT
Erythropoietin did not improve primary outcomes in infants with moderate or severe HIE
Trial shows Erythropoietin does not improve outcomes for infants with HIE
This Phase 3 randomized clinical trial evaluated intravenous Erythropoietin in 313 infants with moderate or severe HIE. The study found no s…
A large trial of 313 infants shows that the drug Erythropoietin does not improve survival or motor skills for babies with brain injury.
Oct 12, 2026
Drug Pipeline
Meta-analysis
G-CSF shows potential signal for neurological grade improvement in acute spinal cord injury
G-CSF Shows Potential for Improving Spinal Cord Injury Recovery
This meta-analysis evaluates the efficacy of G-CSF, EPO, MP, and minocycline for neurological grade improvement in acute spinal cord injury.…
A review of treatments for acute spinal cord injury suggests that G-CSF may help improve neurological grades, though more evidence is needed…
Frontiers
Oct 11, 2026
Orthopedics & Sports Medicine
Sys. Review
Gene doping and microbiome manipulation present dual-use dilemmas for rehabilitation clinicians in elite sports
New technologies create a dilemma for athletes and their doctors
This narrative review explores the overlap between legitimate medical therapies and potential doping in gene, microbiome, and anti-aging tec…
New ways to boost muscle and endurance could be used for both medical healing and illegal sports doping.
Frontiers
Oct 10, 2026
Pediatrics
RCT
Erythropoietin Dynamics and Neuroimaging Outcomes in Extremely Preterm Infants with Retinopathy
Erythropoietin Levels Linked to Brain Injury in Preterm Infants
This post-hoc analysis explores how erythropoietin levels correlate with MRI findings of brain injury and retinopathy in extremely preterm i…
New data explores how erythropoietin levels and blood transfusions impact brain health and eye risks in extremely preterm infants.
Jun 26, 2026